Genetic Testing and Molecular Biomarkers

Aims & Scope

Genetic Testing and Molecular Biomarkers is the leading peer-reviewed journal covering all aspects of human genetic testing including molecular biomarkers.

The Journal provides a forum for the development of new technology; the application of testing to decision making in an increasingly varied set of clinical situations; ethical, legal, social, and economic aspects of genetic testing; and issues concerning effective genetic counseling.

This is the definitive resource for researchers, clinicians, and scientists who develop, perform, and interpret genetic tests and their results.

Genetic Testing and Molecular Biomarkers coverage includes: -Diagnosis across the life span- Risk assessment- Carrier detection in individuals, couples, and populations- Novel methods and new instrumentation for genetic testing- Results of molecular, biochemical, and cytogenetic testing- Genetic counseling

View Aims & Scope

---

Metrics & Ranking

Impact Factor

Year	Value
2025	1
2024	1.10

SJR (SCImago Journal Rank)

Year	Value
2024	0.303

Quartile

Year	Value
2024	Q3

h-index

Year	Value
2024	54

Journal Rank

Year	Value
2024	16547

Journal Citation Indicator

Year	Value
2024	200

---

---

Abstracting & Indexing

Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.

• Scopus
• Google Scholar
• Web of Science
• Medline
• Embase

---

Subjects & Keywords

Journal’s research areas, covering key disciplines and specialized sub-topics in Medicine, designed to support cutting-edge academic discovery.

---

Most Cited Articles

The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.

• Using SIFT and PolyPhen to Predict Loss-of-Function and Gain-of-Function Mutations

  Citation: 332

  Authors: Sarah E., Ann-Marie, Sian

• Public Knowledge of and Attitudes Toward Genetics and Genetic Testing

  Citation: 211

  Authors: Susanne B., William T., Rachel, Geoffrey S., Laura, Jennifer, Huntington F.

• Physicians' Preparedness for Integration of Genomic and Pharmacogenetic Testing into Practice Within a Major Healthcare System

  Citation: 107

  Authors: Christina G., Scott M., Andy, Peter J.

• Relationship Between Leptin G2548A and Leptin Receptor Q223R Gene Polymorphisms and Obesity and Metabolic Syndrome Risk in Tunisian Volunteers

  Citation: 92

  Authors: Imen, Asma, Jihène, Lamia, Amani, Nabila, Naoufel, Ahmed, Ali

• Species Identification Through DNA “Barcodes”

  Citation: 76

  Authors: Gianmarco, Milena, Beatrice, Manuela, Giovanni

• Uptake, Time Course, and Predictors of Risk-Reducing Surgeries in<i>BRCA</i>Carriers

  Citation: 76

  Authors: Mary S., Beth, Feng, Eric, John

• Circulating <i>miRNA-20a</i> and <i>miRNA-203</i> for Screening Lymph Node Metastasis in Early Stage Cervical Cancer

  Citation: 75

  Authors: Shan, Desheng, Junying, Nan

• Screening of 38 Genes Identifies Mutations in 62% of Families with Nonsyndromic Deafness in Turkey

  Citation: 70

  Authors: Duygu, Asli, F. Basak, Hilal, Mustafa

• Obama's Precision Medicine Initiative

  Citation: 69

  Authors: Sharon F.

• Identification of an Exosomal Long Noncoding RNA SOX2-OT in Plasma as a Promising Biomarker for Lung Squamous Cell Carcinoma

  Citation: 66

  Authors: Yun, Hui, Yang

---